Innovative Therapies Days 2024

9–12 Oct 2024 | BESANCON, France

Susanne Behlke

CSO

Med’Inn’Pharma

Besançon, France

12 profile visitsSpeakerGuests

My organisation

MED’INN’Pharma (MIP) is a pre-clinical stage Biotech company founded in 2017 as a spin-off from the French blood bank establishment (EFS) and the French National Institute of Health (INSERM). Our mission is to use our platform technology to develop a pipeline of disease modifying therapies derived from the secretomes of human cells. We are committed to develop drug candidates with durable efficacy by targeting the root cause of diseases. Our platform derived therapeutics can be tailored to several indications and delivery methods. RESOLVIX, the lead candidate issued from our technology plateform, is dedicated to actively resolve, heal and regenerate pathologic inflammation in a wide range of degenerative diseases and conditions and with that intended to positively impacting human health span.
Read more

About me

My organisation

Med’Inn’Pharma

Med’Inn’Pharma (MIP) is a pre-clinical stage Biotech with the mission to develop a new generation of human cell-derived therapeutics with truly disease modifying properties.

We use our propriatery platform to induce human cells to release desired bioactive molecules that we transform into stable biologic drug products. Our first candidates issued from that platform are dedicated to actively resolve pathologic inflammation without suppressing the immune system. By targeting an universal mechanism of regeneration, our candidates are applicable to a wide range of degenerative diseases and conditions intended cure disease and improve health span.

Currently, our priority is to generate clinical proof of concept trials through both autologous self-resolutome & pro-resolutive drug candidate programs.

Speaker sessions (2)

Thursday, 10 October 2024

09:20 - 10:25

Session #1 : Upcoming Innovative Therapies

Format:In-personLocation:Petit Kursaal roomTrack:Conference

11:15 - 12:15

Session #1 : Upcoming Innovative Therapies

Format:In-personLocation:Petit Kursaal roomTrack:Conference